3 These results suggest that robust digital support can optimize dosing, reduce costs and improve adherence
Factors associated with weight loss response to GLP-1 analogues for obesity treatment: a retrospective cohort analysis
For patients preferring oral options, the Wegovy pill offers daily convenience without injections
For "Cardiovascular risk reduction," Semaglutide may be more appropriate
The dominant adverse events in both are gastrointestinal nausea, diarrhea, vomiting, and constipation and in both they are dose-dependent and tend to ease as the body adapts to gradual dose escalation
Patients with a history of pancreatitis, certain thyroid cancers, or severe gastrointestinal disease may need alternative therapies